Improved protein-A separation of V H3 fab from FC after papain digestion of antibodies

Journal of Biomolecular Techniques

Volumn 22, Issue 2, 2012, Pages 50-52

  Seldon, Therese A ^a   Hughes, Karen E ^b   Munster, David J ^a   Chin, David Y ^b   Jones, Martina L ^b  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antibodies; Immunoglobulin; Purification; Staphylococcal; Variable region

Indexed keywords

ALEMTUZUMAB; ANTIBODY; BEVACIZUMAB; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; PAPAIN; PROTEIN A; RESIN; RITUXIMAB; TRASTUZUMAB;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING SITE; IMMUNOGLOBULIN VARIABLE REGION; PURIFICATION; SEPARATION TECHNIQUE;

EID: 84857435187     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mattes MJ. Binding parameters of antibodies reacting with multivalent antigens: functional affinity or pseudo-affinity. J Immunol Methods 1997;202:97-101.
2. Kovari LC, Momany C, Rossmann MG. The use of antibody fragments for crystallization and structure determinations. Structure 1995;3:1291-1293.
3. Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005;23:1126-1136.
4. Ljungberg UK, Jansson B, Niss U, Nilsson R, Sandberg BE, Nilsson B. The interaction between different domains of Staphylococcal Protein A and human polyclonal IgG, IgA, IgM and F(ab')2: separation of affinity from specificity. Mol Immunol 1993;30:1279-1285.
5. Zhao Y, Gutshall L, Jiang H, et al. Two routes for production and purification of Fab fragments in biopharmaceutical discovery research: papain digestion of mAb and transient expression in mammalian cells. Protein Expr Purif 2009;67:182-189.
6. Hillson JL, Karr NS, Oppliger IR, Mannik M, Sasso EH. The structural basis of germline-encoded VH3 immunoglobulin binding to Staphylococcal Protein A. J Exp Med 1993;178:331-336.
7. Starovasnik MA, O'Connell MP, Fairbrother WJ, Kelley RF. Antibody variable region binding by Staphylococcal Protein A: thermodynamic analysis and location of the Fv binding site on E-domain. Protein Sci 1999;8:1423-1431.
8. Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 2010;9:767-774.
9. Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today 1995;16:237-242.
10. Davidkova G, Pettersson S, Holmberg D, Lundkvist I. Selective usage of VH genes in adult human B lymphocyte repertoires. Scand J Immunol 1997;45:62-73.
11. Sheets MD, Amersdorfer P, Finnern R, et al. Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci USA 1998;95:6157-6162.
12. Jespers L, Schon O, Famm K, Winter G. Aggregation-resistant domain antibodies selected on phage by heat denaturation. Nat Biotechnol 2004;22:1161-1165.
13. Nilsson B, Moks T, Jansson B, et al. A synthetic IgG-binding domain based on Staphylococcal Protein A. Protein Eng 1987;1: 107-113.
14. Linhult M, Gulich S, Graslund T, et al. Improving the tolerance of a Protein A analogue to repeated alkaline exposures using a bypass mutagenesis approach. Proteins 2004;55:407-416.
15. Ghose S, Allen M, Hubbard B, Brooks C, Cramer SM. Antibody variable region interactions with Protein A: implications for the development of generic purification processes. Biotechnol Bioeng 2005;92:665-673.
16. Magdelaine-Beuzelin C, Kaas Q, Wehbi V, et al. Structurefunction relationships of the variable domains of monoclonal antibodies approved for cancer treatment. Crit Rev Oncol Hematol 2007;64:210-225.
17. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008;36:W503-W508.